UNSPSC 51292920: Imipramine embonate

This classification denotes a tricyclic antidepressant with the molecular formula C23H16O6.2C19H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MC34P30298. European Medicines Agency schedules imipramine embonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02643MIG. The term imipramine embonate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule imipramine embonate under HS 29339990.

SMILES: CN(C)CCCN1C2CCCCC2CCC3C1CCCC3.CN(C)CCCN1C2CCCCC2CCC3C1CCCC3.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51292920 Imipramine embonate is a Commodity code for a specific pharmaceutical product, but the recent state and local procurement activity identified under this code does not reflect imipramine purchases. Seminole County, Florida posted IFB 60459723LAS in June 2026 to procure naloxone and safe drug deactivation systems—a substantial mismatch with the code's nominal scope. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. This procurement supports community health initiatives rather than psychiatric pharmaceutical supply. Vendors were required to submit bids electronically, include all shipping and delivery costs in proposals, maintain workers' compensation and commercial general liability insurance, and satisfy E-Verify compliance and drug-free workplace certification. The contract carried a two-year initial term with a one-year renewal option and was potentially funded through FEMA, triggering additional federal compliance requirements.

The code shows limited recent activity aligned with its stated pharmaceutical product scope. The single available opportunity—Seminole County's naloxone procurement—represents a misalignment between the UNSPSC classification and the actual work being solicited. The response deadline for the Seminole County IFB was July 26, 2023, which has already passed. No current or upcoming imipramine embonate solicitations appear in recent state and local contracting activity, suggesting this Commodity code does not reflect active procurement demand in the state and local market at this time.